Background Tuberous sclerosis complex is highly variable in clinical presentation and
findings. Disease manifestations continue to develop over the lifetime of an affected individual. …

Background Antibodies against HLA antigens cause refractory allograft rejection with
vasculopathy in some, but not all, patients. Methods We studied 33 kidney-transplant recipients …

Background Angiomyolipomas are slow-growing tumours associated with constitutive activation
of mammalian target of rapamycin (mTOR), and are common in patients with tuberous …

Background Tuberous sclerosis complex is a genetic disorder affecting every organ system,
but disease manifestations vary significantly among affected individuals. The diverse and …

Background Autosomal dominant polycystic kidney disease (ADPKD) is a slowly progressive
hereditary disorder that usually leads to end-stage renal disease. Although the underlying …

Patients with kidney failure are at increased risk of SARS-CoV-2 infection, making effective
vaccinations a critical need. It is not known how well mRNA vaccines induce B and plasma …

Background Tuberous sclerosis complex (TSC) is an autosomal dominant genetic disease
affecting multiple body systems with wide variability in presentation. In 2013, Pediatric …

Novel mRNA-based vaccines have been proven to be powerful tools in combating the global
pandemic caused by SARS-CoV-2, with BNT162b2 (trade name: Comirnaty) efficiently …

Ten years ago, a consensus report on the optimization of tacrolimus was published in this
journal. In 2017, the Immunosuppressive Drugs Scientific Committee of the International …

Background Non-nephrotoxic immunosuppressive strategies that allow reduction of
calcineurin-inhibitor exposure without compromising safety or efficacy remain a goal in kidney …